4,756 Shares in Danaher Corporation $DHR Bought by StoneRidge PMG Advisors LLC

StoneRidge PMG Advisors LLC purchased a new stake in Danaher Corporation (NYSE:DHR) during the third quarter, HoldingsChannel.com reports. The firm purchased 4,756 shares of the conglomerate’s stock, valued at approximately $1,054,000. Danaher accounts for about 0.7% of StoneRidge PMG Advisors LLC’s investment portfolio, making the stock its 29th largest position.

Other institutional investors also recently made changes to their positions in the company. Main Street Group LTD acquired a new stake in shares of Danaher during the 1st quarter worth $25,000. N.E.W. Advisory Services LLC acquired a new position in Danaher in the second quarter valued at $25,000. Marquette Asset Management LLC boosted its holdings in Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 73 shares during the last quarter. Field & Main Bank purchased a new stake in Danaher during the second quarter valued at about $29,000. Finally, Solstein Capital LLC purchased a new stake in Danaher during the second quarter valued at about $33,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Morgan Stanley upped their price target on Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research note on Monday, October 12th. Robert W. Baird lifted their price objective on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. Guggenheim lifted their price objective on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. JPMorgan Chase & Co. boosted their target price on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Finally, Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $242.91.

Danaher Stock Performance

NYSE:DHR opened at $230.34 on Monday. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $162.05 billion, a price-to-earnings ratio of 37.70, a PEG ratio of 2.89 and a beta of 0.76. The firm’s fifty day simple moving average is $220.27 and its 200 day simple moving average is $201.60. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. During the same period in the prior year, the firm earned $1.89 EPS. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. As a group, equities research analysts expect that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio is presently 26.19%.

Insider Buying and Selling at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares in the company, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 10.80% of the stock is owned by insiders.

Danaher Company Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.

The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.